Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.

Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Pellagatti, A, Boultwood, J
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	Elsevier 2016

Antzeko izenburuak

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
nork: Armstrong, R, et al.
Argitaratua: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
nork: Boultwood, J, et al.
Argitaratua: (2014)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
nork: Pellagatti, A, et al.
Argitaratua: (2017)

Gene expression profiling in the myelodysplastic syndromes.
nork: Pellagatti, A, et al.
Argitaratua: (2005)

Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
nork: Johanna Flach, et al.
Argitaratua: (2020-09-01)

SF3B1 mutant myelodysplastic syndrome: Recent advances
nork: Pellagatti, A, et al.
Argitaratua: (2020)

Lack of splice factor and cohesin complex mutations in pediatric myelodysplastic syndrome
nork: Julia C. Obenauer, et al.
Argitaratua: (2016-12-01)

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
nork: Yip, B, et al.
Argitaratua: (2017)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
nork: Boultwood, J, et al.
Argitaratua: (2009)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
nork: Boultwood, J, et al.
Argitaratua: (1991)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
nork: Pellagatti, A, et al.
Argitaratua: (2003)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
nork: Fernandez-Mercado, M, et al.
Argitaratua: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
nork: Fernandez-Mercado, M, et al.
Argitaratua: (2013)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
nork: Fernandez-Mercado, M, et al.
Argitaratua: (2010)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
nork: Fernandez-Mercado, M, et al.
Argitaratua: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
nork: Boultwood, J, et al.
Argitaratua: (2010)

Clonality in the myelodysplastic syndromes.
nork: Boultwood, J, et al.
Argitaratua: (2001)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
nork: Marta Fernandez-Mercado, et al.
Argitaratua: (2013-12-01)

The impact of spliceosome mutations in MDS
nork: Jacqueline Boultwood, et al.
Argitaratua: (2019-06-01)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
nork: Steensma, D, et al.
Argitaratua: (2004)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
nork: Pellagatti, A, et al.
Argitaratua: (2008)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
nork: Dolatshad, H, et al.
Argitaratua: (2016)

Discovering transcription and splicing networks in myelodysplastic syndromes.
nork: Hongyan Wang, et al.
Argitaratua: (2013-01-01)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
nork: Bernard, E, et al.
Argitaratua: (2020)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
nork: Pellagatti, A, et al.
Argitaratua: (2009)

Molecular pathogenesis of the myelodysplastic syndromes
nork: Boultwood, J, et al.
Argitaratua: (1999)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
nork: Liberante, F, et al.
Argitaratua: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
nork: Liberante, F, et al.
Argitaratua: (2013)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
nork: Pellagatti, A, et al.
Argitaratua: (2010)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
nork: Watkins, F, et al.
Argitaratua: (2004)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
nork: Pellagatti, A, et al.
Argitaratua: (2014)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
nork: Boultwood, J
Argitaratua: (2009)

Telomere length in myelodysplastic syndromes.
nork: Boultwood, J, et al.
Argitaratua: (1995)

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
nork: Iva Trsova, et al.
Argitaratua: (2023-12-01)

Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes.
nork: Boultwood, J, et al.
Argitaratua: (1990)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
nork: Pellagatti, A, et al.
Argitaratua: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
nork: Pellagatti, A, et al.
Argitaratua: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
nork: Pellagatti, A, et al.
Argitaratua: (2010)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
nork: Boultwood, J
Argitaratua: (2009)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
nork: Zhang, J, et al.
Argitaratua: (2004)